Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Paul W. M. Verhezen"'
Autor:
Anne-Marije Hulshof, Renske H. Olie, Minka J. A. Vries, Paul W. M. Verhezen, Paola E. J. van der Meijden, Hugo ten Cate, Yvonne M. C. Henskens
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Aims: Patients using antithrombotic drugs after percutaneous coronary intervention (PCI) are at risk for bleeding and recurrent ischemia. We aimed to explore routine and tissue plasminogen activated (tPA) ROTEM results in a post-PCI population on dua
Externí odkaz:
https://doaj.org/article/aaba5e75ed38495885ccd269e845d179
Autor:
Floor C. J. I. Moenen, Minka J. A. Vries, Patricia J. Nelemans, Katrien J. M. van Rooy, Jeannique R. R. A. Vranken, Paul W. M. Verhezen, Rick J. H. Wetzels, Hugo ten Cate, Harry C. Schouten, Erik A. M. Beckers, Yvonne M. C. Henskens
Publikováno v:
Platelets, Vol 30, Iss 1, Pp 81-87 (2019)
Light transmission aggregation (LTA) is the gold standard for the diagnosis of platelet function disorders (PFDs), but it is time-consuming and limited to specialized laboratories. Whole-blood impedance aggregometry (Multiplate) and platelet function
Externí odkaz:
https://doaj.org/article/821cf6888da845dc965608ac3a7db84b
Autor:
Gerhardus J. A. J. M. Kuiper, Rik Houben, Rick J. H. Wetzels, Paul W. M. Verhezen, Rene van Oerle, Hugo ten Cate, Yvonne M. C. Henskens, Marcus D. Lancé
Publikováno v:
Platelets, Vol 28, Iss 7, Pp 668-675 (2017)
Low platelet counts and hematocrit levels hinder whole blood point-of-care testing of platelet function. Thus far, no reference ranges for MEA (multiple electrode aggregometry) and PFA-100 (platelet function analyzer 100) devices exist for low ranges
Externí odkaz:
https://doaj.org/article/7823c5d51c6f4df3a38323b1056abd94
Autor:
Floor C. J. I. Heubel‐Moenen, Sanne L. N. Brouns, Linda Herfs, Lara S. Boerenkamp, Natalie J. Jooss, Rick J. H. Wetzels, Paul W. M. Verhezen, Patric Machiels, Karyn Megy, Kate Downes, Johan W. M. Heemskerk, Erik A. M. Beckers, Yvonne M. C. Henskens
Publikováno v:
British Journal of Haematology, 196(6), 1388-1400. Wiley
Patients referred for evaluation of bleeding symptoms occasionally have a prolonged platelet function analyser (PFA) closure time, without evidence for von Willebrand disease or impaired platelet aggregation. The aim of this study was to establish a
Autor:
Floor C. J. I. Heubel‐Moenen, Loes E. M. Ansems, Paul W. M. Verhezen, Rick J. H. Wetzels, Rene G. M. van Oerle, Ron J. M. H. E. Straat, Karyn Megy, Kate Downes, Yvonne M. C. Henskens, Erik A. M. Beckers, Manuela A. Joore
Publikováno v:
British Journal of Haematology, 200(6), 792-801. Wiley
The diagnostic work-up of patients referred to the haematologist for bleeding evaluation is performed in a stepwise way: bleeding history and results of screening laboratory tests guide further diagnostic evaluation. This can be ineffective, time-con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a30c9272e8137952ca4ba8773b5e30
Autor:
Demi S. Post, Arian van der Veer, Olaf E. M. G. Schijns, Sylvia Klinkenberg, Kim Rijkers, G. Louis Wagner, Vivianne H. J. M. van Kranen-Mastenbroek, Paul C. P. H. Willems, Paul W. M. Verhezen, Erik A. M. Beckers, Floor C. J. I. Heubel-Moenen, Yvonne M. C. Henskens
Publikováno v:
PLOS ONE, 17(2):e0264351. Public Library of Science
Introduction Valproic acid (VPA) is a frequently prescribed anti-epileptic drug. Since its introduction side effects on hemostasis are reported. However, studies show conflicting results, and the clinical relevance is questioned. We aimed to determin
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 158
Von Willebrand factor (VWF) is a multimeric adhesive protein that binds platelets to exposed subendothelium and carries factor VIII in the circulation. VWD is classified into three major subtypes, distinguished by a quantitative deficiency of VWF (ty
Autor:
Demi S Post, Arian van der Veer, Olaf E M G Schijns, Sylvia Klinkenberg, Kim Rijkers, G Louis Wagner, Vivianne H J M van Kranen-Mastenbroek, Paul C P H Willems, Paul W M Verhezen, Erik A M Beckers, Floor C J I Heubel-Moenen, Yvonne M C Henskens
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0264351 (2022)
IntroductionValproic acid (VPA) is a frequently prescribed anti-epileptic drug. Since its introduction side effects on hemostasis are reported. However, studies show conflicting results, and the clinical relevance is questioned. We aimed to determine
Externí odkaz:
https://doaj.org/article/00f4153321684ea989cf14475877706e